1-4 of 4
Eva González-Barca
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The role of miR-150-5p/E2F3/survivin axis in the pathogenesis of plasmablastic lymphoma and its therapeutic potential

Miriam Verdu-Bou, Maria Joao Baptista, Marcelo Lima Ribeiro, Aleix Méndez López, Nuria Profitos-Peleja, Fabian Frontzek, Gael Roue, José Luís Mate, Mireia Pellicer, Pau Abrisqueta, Josep Castellví, Mariana Beatriz Bastos Oreiro, Javier Menarguez, Miguel Alcoceba, Eva González Barca, Dr, Fina Climent, Antonio Salar, Juan Manuel Sancho, Annette M. Staiger, German Ott, Ioannis Anagnostopoulos, Manel Esteller, Georg Lenz, Gustavo Tapia, José-Tomás Navarro
Journal: Blood Advances
Blood Adv bloodadvances.2025016180.
https://doi.org/10.1182/bloodadvances.2025016180
Published: 2025
Includes: Supplemental data
Journal Articles

Mosunetuzumab plus Pola-CHP compared with Pola-R-CHP in previously untreated DLBCL: final results from a Phase II study

Clinical Trials & Observations
Jason R Westin, Tycel J. Phillips, Amitkumar Mehta, Marc S Hoffmann, Eva Gonzalez-Barca, Catherine Thieblemont, Mariana Bastos-Oreiro, Richard Greil, Sebastian Giebel, Michael C. Wei, Jue Wang, Reinhard Bucher, Jason Sit, Elicia Penuel, Enkhtsetseg Purev, Donald L Yee, Juan Miguel Bergua Burgues
Journal: Blood Advances
Blood Adv bloodadvances.2024014907.
https://doi.org/10.1182/bloodadvances.2024014907
Published: 2025
Includes: Supplemental data
Journal Articles

Phase 1b study of the BET protein inhibitor RO6870810 with venetoclax and rituximab in patients with diffuse large B-cell lymphoma

Clinical Trials & Observations
Michael Dickinson, Javier Briones, Alex F. Herrera, Eva González-Barca, Nilanjan Ghosh, Raul Cordoba, Sarah C. Rutherford, Eirini Bournazou, Emily Labriola-Tompkins, Izolda Franjkovic, Evelyne Chesne, Jurriaan Brouwer-Visser, Katharina Lechner, Barbara Brennan, Eveline Nüesch, Mark DeMario, Dominik Rüttinger, Martin Kornacker, Martin Hutchings
Journal: Blood Advances
Blood Adv (2021) 5 (22): 4762–4770.
https://doi.org/10.1182/bloodadvances.2021004619
Published: 2021
Includes: Supplemental data
Journal Articles

End-of-treatment PET/CT predicts PFS and OS in DLBCL after first-line treatment: results from GOYA

Clinical Trials & Observations
Lale Kostakoglu, Maurizio Martelli, Laurie H. Sehn, David Belada, Angelo-Michele Carella, Neil Chua, Eva Gonzalez-Barca, Xiaonan Hong, Antonio Pinto, Yuankai Shi, Yoichi Tatsumi, Andrea Knapp, Federico Mattiello, Tina Nielsen, Deniz Sahin, Gila Sellam, Mikkel Z. Oestergaard, Umberto Vitolo, Marek Trněný
Journal: Blood Advances
Blood Adv (2021) 5 (5): 1283–1290.
https://doi.org/10.1182/bloodadvances.2020002690
Published: 2021
Includes: Supplemental data